MedPath

Impact of Treatment of Periodontis on Endothelial Function in Patients With Obstructive Sleep Apnea

Not Applicable
Terminated
Conditions
Cardiovascular Disease in Obstructive Sleep Apnea
Interventions
Procedure: scaling and root planing
Registration Number
NCT02573116
Lead Sponsor
Hopital Foch
Brief Summary

Evaluation of the add-on effect on endothelial dysfunction of treatment of periodontitis in patients with chronic periodontitis and severe obstructive sleep apnea treated by CPAP. Patients with and without chronic periodontitis will be treated by CPAP for 20 weeks. At V2 (10 weeks), endothelial dysfunction will be assessed by the Reactive Hyperemia- Peripheral Artery Tone index. The endothelial dysfunction of the patients will be also assessed at V3 (20 weeks) after periodontitis treatment for the group of patients with chronic periodontitis.

Detailed Description

At V2, patients with periodontitis will have full-mouth intensive removal of denatl plaque biofilms with the use of scaling and root planing. The add-on effect of the periodontitis treatment on endothelial dysfunction will be assessed ten weeks later (V3) in comparison with V2 by taking into account with the effect of 10 weeks of CPAP in the control group with severe OSA but not periodontitis.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
49
Inclusion Criteria
  • severe OSA defined by an apnea hypopnea index > or = 30 per hour
  • with or without chronic parodontitis
Read More
Exclusion Criteria
  • non equilibrated diabetes
  • obesity (BMI > or = 40)
  • active smoker (> 1 pack per day (20 cigarettes))
  • pregnancy
  • antibiotics within the preceding three months
  • prophylactic antibiotherapy required for the parodontitis treatment
  • acute parodontitis or all parontal pathology requiring immediate therapy
  • less than 10 teeth
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Obstructive sleep apnea with chronic parodontisscaling and root planingpatients with severe obstructive sleep apnea (OSA) and chronic parodontis treated for OSA by continuous positive airway pressure (CPAP) and intensive periodontal treatment
Primary Outcome Measures
NameTimeMethod
Endothelial function20 weeks

measure of Reactive Hyperemia- Peripheral Artery Tone index with Endopat

Secondary Outcome Measures
NameTimeMethod
Endothelial function10 weeks

measure of Reactive Hyperemia- Peripheral Artery Tone index with Endopat

blood biomarkers0, 10 and 20 weeks

hsCRP, leptin, adiponectin, E-selectin and orosomucoid

Epworth Sleepiness Scale0, 10 and 20 weeks

Trial Locations

Locations (1)

Hôpital Foch

🇫🇷

Suresnes, France

© Copyright 2025. All Rights Reserved by MedPath